UCB SA (UCB)

84.04
-1.26(-1.48%)
  • Volume:
    134,888
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    81.82 - 84.20
  • Type:Equity
  • Market:Belgium
  • ISIN:BE0003739530

UCB Overview

Prev. Close
85.3
Day's Range
81.82-84.2
Revenue
5.78B
Open
82
52 wk Range
74.74-116.05
EPS
5.43
Volume
134,888
Market Cap
15.89B
Dividend (Yield)
0.91
(1.07%)
Average Volume (3m)
362,026
P/E Ratio
15.70
Beta
0.54
1-Year Change
-3.88%
Shares Outstanding
189,173,877
Next Earnings Date
27 Jul 2022
What is your sentiment on UCB?
or
Vote to see community's results!

UCB SA News

  • UCB Earnings, Revenue miss in Q4
    • ByInvesting.com-

    Investing.com - UCB reported on Thursday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations. UCB announced earnings per share of...

  • Zogenix Surges After UCB's $1.9B Acquisition Offer
    • ByInvesting.com-

    By Sam BougheddaInvesting.com — Shares of Zogenix Inc (NASDAQ:ZGNX) surged over 67% Wednesday after UCB SA (BR:UCB) said it has agreed to acquire the epilepsy drug maker for...

  • UCB Earnings miss, Revenue beats In Q2
    • ByInvesting.com-

    Investing.com - UCB reported on Thursday second quarter earnings that missed analysts' forecasts and revenue that topped expectations. UCB announced earnings per share of...

UCB SA Company Profile

UCB SA Company Profile

Employees
8284
Market
Belgium

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyBuyNeutralSell
Technical IndicatorsStrong BuyBuyBuyStrong BuySell
SummaryStrong BuyBuyBuyBuySell